Overview of EU MDR Compliance for Importers in 2026
Under the Medical Device Regulation (EU) 2017/745 (MDR), importers act as the first economic operator in the EU supply chain and bear significant responsibility for ensuring medical devices placed on the market are safe, perform as intended, and fully comply with regulatory requirements. Article 13 outlines their core obligations, which apply year-round but gain urgency in 2026 due to mandatory EUDAMED rollout deadlines. Non-compliance can lead to market withdrawal, fines, or bans. Below is a step-by-step guide to meeting these rules, tailored to 2026 timelines.
Key Steps for Importers
- Verify Device Conformity Before Market Placement
Confirm the device has a valid CE marking, EU declaration of conformity, identifiable manufacturer details, and an authorized representative (per Article 11). Do not import or place non-compliant devices on the market. For legacy devices (pre-MDR certificates), ensure they meet transition deadlines: e.g., Class III custom-made implantables by May 26, 2026. - Check and Maintain Labeling, Instructions, and UDI
Ensure the device, packaging, and instructions for use include all required information (Annex I), such as the importer’s name, registered trade name or trademark, address, and contact details—without obscuring manufacturer info. Verify Unique Device Identification (UDI) assignment per Article 27. Update labels if needed to reflect importer details. - Register in EUDAMED’s Actor Module (Mandatory from Q2 2026)
Obtain a Single Registration Number (SRN) by registering as an economic operator in the Actor Registration Module by Q2 2026 (around April–June). This is required for all importers handling MDR/IVDR devices. Use the SRN for subsequent interactions. - Register Devices in EUDAMED’s Medical Device Module
For new devices placed on the market after May 28, 2026, register them immediately in the Medical Device Registration Module before first placement (include UDI, basic device data, and certificates). For devices already on the market before May 2026, complete registration by Q4 2026 if they remain active. Verify prior manufacturer registrations (Article 29) and add importer details (Article 31). - Ensure Proper Storage and Transport Conditions
Maintain environmental conditions during storage and transport that preserve the device’s safety and performance (per Annex I and manufacturer specs). Document these processes to demonstrate compliance. - Establish Record-Keeping and Traceability Systems
Keep a register of complaints, non-conforming devices, and field safety corrective actions (recalls/withdrawals). Retain the EU declaration of conformity (and any certificates) for at least the device’s lifetime plus post-market period (up to 15 years for implants, per Article 10(8)). Share relevant info with manufacturers, authorized representatives, and distributors. - Monitor, Report, and Address Non-Compliances or Incidents
If a non-conformity is suspected, immediately inform the manufacturer/representative and halt distribution. Report serious incidents, risks, or falsified devices to competent authorities (Article 87) and, if applicable, the notified body (Article 56). Forward user complaints (from healthcare professionals, patients, or users) to the manufacturer. Cooperate on corrective actions, including withdrawals or recalls. - Cooperate with Authorities and Audits
Assist competent authorities in mitigating risks by providing documentation, free samples, or site access upon request. Stay prepared for inspections, as importers may face audits to verify compliance.
Additional 2026 Considerations
- EUDAMED Phased Rollout: Full mandatory use of Actor and Device modules starts May 28, 2026; delays could block market access. Test voluntary registration in early 2026 to prepare.
- Legacy Device Transition: By end-2026, most higher-risk legacy devices must transition to full MDR certification—importers should coordinate with manufacturers to avoid supply disruptions.
- Resources: Consult the European Commission’s Blue Guide for practical implementation and EUDAMED user manuals. Engage a notified body or consultant if handling complex classifications.
By following these steps proactively, importers can mitigate risks and ensure seamless market access in 2026 and beyond. For device-specific advice, refer to a regulatory expert.